Bayer plans to restructure in order invest its resources in growing the company and enhancing its capabilities. The focus will be on R&D and marketing new products, particularly in HealthCare and CropScience, as well as expanding activities in emerging markets. As a result, the company will reduce its global headcount of 108,700 by approximately 2,000 by 2012. In total 4,500 positions, including 1,700 in Germany will be cut, while 2,500 new jobs will be created over the same period, particul...